Sinovac Biotech Ltd. (SVA) News
Follow Sinovac Biotech Ltd. (SVA) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 6 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
H
Sernova Biotherapeutics to Participate in Noble Capital Markets’ Emerging Growth Virtual Equity Conference
Jonathan Rigby and Will Rust, Ph.D., to Discuss Proposed Merger to Form BetaNova Biotherapeutics and Advance a Differentiated Type 1 Diabetes Cell-Replacement PlatformTORONTO and GERMANTOWN, Md., Sept. 25, 2026 (GLOBE NE
MNA | Sep 25, 2026, 11:01 AM UTC
L
Sernova shareholder backs Seraxis takeover proposal
Content provided by Seeking Alpha is intended for information purposes only, and that Seeking Alpha does not offer any personalist investment advice and is not a licensed securities dealer, broker, US investment adviser
MNA | Sep 11, 2026, 09:51 PM UTC
L
Steven Sangha Announces Voting and Support Agreement for Sernova Biotherapeutics Inc.'s Proposed Business Combination with Seraxis Holdings, Inc.
Toronto, Ontario--(. - September 11, 2026) - Steven Sangha announces he has entered into a voting and support agreement ("Voting Agreement") with Seraxis Holdings, Inc. ("Seraxis") in connection with Seraxis's proposal (
MNA | Sep 11, 2026, 09:41 PM UTC
L
HC Wainwright cuts Sinovac Biotech price target to $1.00
HC Wainwright & Co. cut its price target for Sinovac Biotech to $1.00 per share from $6.00, according to Benzinga ratings actions.
EQUITY | Sep 08, 2026, 05:47 PM UTC
H
Sernova, Seraxis sign definitive merger agreement
Sernova Biotherapeutics and Seraxis Holdings announced a definitive agreement to combine their technologies and businesses into BetaNova Biotherapeutics, a clinical-stage type 1 diabetes islet cell-replacement company.
MNA | Sep 08, 2026, 11:12 AM UTC
M
Sinovac (SVA) reports unaudited first-half 2026 financial results
Sinovac (SVA) reports unaudited first half of 2026 financial results, with no further figures or commentary provided in the alert.
EQUITY | Aug 17, 2026, 12:08 PM UTC